Home
|
Inbox
|
Search
|
Speaker
Lutz Wollin
PhD
Boehringer Ingelheim Pharma GmbH & Co. KG
Session(s)
- The Matrix-Fibroblast Interplay: Nintedanib and Pirfenidone Modulate the Effect of IPF Fib...
Sunday, May 20 11:15 AM - 1:00 PM - Molecular Evidences for Antifibrotic Potentials of Nintedanib in Interstitial Lung Disease...
Tuesday, May 22 9:15 AM - 11:15 AM - Nintedanib Treatment Attenuates Pulmonary Fibrosis in A New Humanized Mouse Model for IPF ...
Tuesday, May 22 11:15 AM - 1:00 PM - Pirfenidone Attenuates Pro-Fibrotic Biomarker in Ex Vivo Lung Tissue Slices [Board No. P27...
Tuesday, May 22 11:15 AM - 1:00 PM
|
Home
|
Inbox
|
Search
|